Tailstorm Health KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or recall — FDA D-0500-2025
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Overview of recall records associated with Tailstorm Health INC, including dates, categories and classifications where available.
Classification mix: Class II: 6.
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
This page summarizes recall records in which the official source identifies Tailstorm Health INC as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.